Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response

The introduction of a direct-acting antiviral (DAA) for patients with hepatitis C virus (HCV) infection, could lead to higher sustained virologic response (SVR) rates with fewer adverse events, and it could shorten the treatment duration relative to the interferon era. Although most recent clinical...

Full description

Saved in:
Bibliographic Details
Published in:World J Hepatol
Main Authors: Sasaki, Reina, Kanda, Tatsuo, Kato, Naoya, Yokosuka, Osamu, Moriyama, Mitsuhiko
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2018
Subjects:
Editorial
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6323517/
https://ncbi.nlm.nih.gov/pubmed/30631394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i12.898
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items